Search

Your search keyword '"Jang, Se Yong"' showing total 287 results
Start Over Author "Jang, Se Yong"
287 results on '"Jang, Se Yong"'

7. Long-term clinical outcomes of image-guided percutaneous coronary intervention in acute myocardial infarction from the Korea Acute Myocardial Infarction Registry.

Author

Kwon, Youngjoon, Kim, Namkyun, Kim, Chang-Yeon, Kim, Do-Hoon, Shin, Hyewon, Jung, Min-Su, Park, Jong Sung, Park, Yoon Jung, Park, Bo Eun, Kim, Hong Nyun, Jang, Se Yong, Bae, Myung Hwan, Lee, Jang Hoon, Yang, Dong Heon, Park, Hun Sik, Cho, Yongkeun, Cha, Kwang Soo, Hur, Seung-Ho, Hwang, Jin-Yong, and Jeong, Myung Ho

Subjects
MYOCARDIAL infarction, PERCUTANEOUS coronary intervention, CORONARY vasospasm, INTRAVASCULAR ultrasonography, OPTICAL coherence tomography, PROPENSITY score matching
Abstract

Imaging modalities for percutaneous coronary intervention (PCI), such as intravascular ultrasound (IVUS) or optical coherence tomography (OCT), have increased in the current PCI era. However, their clinical benefits in acute myocardial infarction (AMI) have not been fully elucidated. This study investigated the long-term outcomes of image-guided PCI in patients with AMI using data from the Korean Acute Myocardial Infarction Registry. A total of 9,271 patients with AMI, who underwent PCI with second-generation drug-eluting stents between November 2011 and December 2015, were retrospectively examined, and target lesion failure (TLF) at 3 years (defined as the composite of cardiac death, target vessel myocardial infarction, and ischemia-driven target lesion revascularization) was evaluated. From the registry, 2,134 patients (23.0%) underwent image-guided PCI (IVUS-guided: n = 1,919 [20.6%]; OCT-guided: n = 215 patients [2.3%]). Based on propensity score matching, image-guided PCI was associated with a significant reduction in TLF (hazard ratio: 0.76; 95% confidence interval: 0.59–0.98, p = 0.035). In addition, the TLF incidence in the OCT-guided PCI group was comparable to that in the IVUS-guided PCI group (5.3% vs 4.7%, p = 0.903). Image-guided PCI, including IVUS and OCT, is associated with favorable clinical outcomes in patients with AMI at 3 years post-intervention. Additionally, OCT-guided PCI is not inferior to IVUS-guided PCI in patients with AMI. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Long‐term impact of angiotensin receptor‐neprilysin inhibitor based on short‐term treatment response in heart failure

Author

Park, Hyuk Kyoon, primary, Park, Jong Sung, additional, Kim, Myeong Seop, additional, Lee, Eunkyu, additional, Choi, Hyohun, additional, Park, Yoon Jung, additional, Park, Bo Eun, additional, Kim, Hong Nyun, additional, Kim, Namkyun, additional, Bae, Myung Hwan, additional, Lee, Jang Hoon, additional, Park, Hun Sik, additional, Cho, Yongkeun, additional, Jang, Se Yong, additional, and Yang, Dong Heon, additional

Published
2023
Full Text
View/download PDF

20. Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure

Author

Jang, Se Yong, Chae, Shung Chull, Bae, Myung Hwan, Lee, Jang Hoon, Yang, Dong Heon, Park, Hun Sik, Cho, Yongkeun, Cho, Hyun-Jai, Lee, Hae-Young, Oh, Byung-Hee, Choi, Jin-Oh, Jeon, Eun-Seok, Kim, Min-Seok, Lee, Sang Eun, Kim, Jae-Joong, Hwang, Kyung-Kuk, Cho, Myeong-Chan, Baek, Sang Hong, Kang, Seok-Min, Choi, Dong-Ju, Yoo, Byung-Su, Ahn, Youngkeun, Kim, Kye Hun, and Park, Hyun-Young

Published
2018
Full Text
View/download PDF

21. The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure

Author

Park, Jin Joo, Kim, Sun-Hwa, Oh, Il-Young, Choi, Dong-Ju, Park, Hyun-Ah, Cho, Hyun-Jai, Lee, Hae-Young, Cho, Jae-Yeong, Kim, Kye Hun, Son, Jung-Woo, Yoo, Byung-Su, Oh, Jaewon, Kang, Seok-Min, Baek, Sang Hong, Lee, Ga Yeon, Choi, Jin Oh, Jeon, Eun-Seok, Lee, Sang Eun, Kim, Jae-Joong, Lee, Ju-Hee, Cho, Myeong-Chan, Jang, Se Yong, Chae, Shung Chull, and Oh, Byung-Hee

Published
2018
Full Text
View/download PDF

24. THE ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND VENOUS THROMBOEMBOLIC DISEASE IN HEALTHY ADULTS: A NATIONWIDE STUDY OF KOREAN PEOPLE

Author

Kim, Namkyun, primary, Kim, Chang-Yeon, additional, Roh, Jae-Hyung, additional, Jung, Min Su, additional, Kwon, Youngjoon, additional, Park, Jong Sung, additional, Kim, Hong Nuyn, additional, Jang, Se Yong, additional, Bae, Myung Hwan, additional, Lee, Jang Hoon, additional, Yang, Dong Heon, additional, park, hun sik, additional, and Cho, Yongkeun, additional

Published
2023
Full Text
View/download PDF

25. Association between office visit intervals and long‐term cardiovascular risk in hypertensive patients.

Author

Kim, Duon, Jeong, Hyunmook, Kim, Suhyun, Shin, Ho‐Gyun, Park, Kyun‐Ik, Lee, Seung‐Pyo, Lee, Hee‐Sun, Lee, Ju‐Yeun, Kim, Kwang‐il, Kang, Si‐Hyuck, Lee, Jang Hoon, Jang, Se Yong, Lee, Ju‐Hee, Kim, Kye Hun, Cho, Jae Yeong, Park, Jae‐Hyeong, Park, Sue K., Kim, Seungyeon, Kim, Kwangsoo, and Lee, Hae‐Young

Abstract

Hypertension is a chronic disease that requires long‐term follow‐up in many patients, however, optimal visit intervals are not well‐established. This study aimed to evaluate the incidences of major cardiovascular events (MACEs) according to visit intervals. We analyzed data from 9894 hypertensive patients in the Korean Hypertension Cohort, which enrolled and followed up 11,043 patients for over 10 years. Participants were classified into five groups based on their median visit intervals (MVIs) during the 4‐year period and MACEs were compared among the groups. The patients were divided into clinically relevant MVIs of one (1013; 10%), two (1299; 13%), three (2732; 28%), four (2355; 24%), and six months (2515; 25%). The median follow‐up period was 5 years (range: 1745 ± 293 days). The longer visit interval groups did not have an increased cumulative incidence of MACE (12.9%, 11.8%, 6.7%, 5.9%, and 4%, respectively). In the Cox proportional hazards model, those in the longer MVI group had a smaller hazard ratio (HR) for MACEs or all‐cause death: 1.77 (95% confidence interval [CI], 1.45–2.17), 1.7 (95% CI: 1.41–2.05), 0.90 (95% CI: 0.74–1.09) and 0.64 (95% CI: 0.52–0.79), respectively (Reference MVI group of 75–104 days). In conclusion, a follow‐up visits with a longer interval of 3–6 months was not associated with an increased risk of MACE or all‐cause death in hypertensive patients. Therefore, once medication adjustment is stabilized, a longer interval of 3–6 months is reasonable, reducing medical expenses without increasing the risk of cardiovascular outcomes. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA 2 DS 2 ‐VASc score of 0

Author

Choi, Hyohun, primary, Bae, Myung Hwan, additional, Park, Yoon Jung, additional, Park, Hyuk Kyoon, additional, Lee, Eunkyu, additional, Kim, Myeong Seop, additional, Park, Jong Sung, additional, Kim, Hyeon Jeong, additional, Park, Bo Eun, additional, Kim, Hong Nyun, additional, Kim, Namkyun, additional, Lee, Jang Hoon, additional, Jang, Se Yong, additional, Yang, Dong Heon, additional, Park, Hun Sik, additional, and Cho, Yongkeun, additional

Published
2023
Full Text
View/download PDF

27. Impact of Positron Emission Tomography Viability Imaging: Guided Revascularizations on Clinical Outcomes in Patients With Myocardial Scar on Single-Photon Emission Computed Tomography Scans

Author

Park, Jong Sung, primary, Lee, Jang Hoon, additional, Hong, Chae Moon, additional, Park, Bo Eun, additional, Park, Yoon Jung, additional, Kim, Hong Nyun, additional, Kim, Namkyun, additional, Jang, Se Yong, additional, Bae, Myung Hwan, additional, Yang, Dong Heon, additional, Park, Hun Sik, additional, and Cho, Yongkeun, additional

Published
2023
Full Text
View/download PDF

29. Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort

Author

Lee, Jin Young, primary, Bak, Jean Kyung, additional, Kim, Mina, additional, Shin, Ho-Gyun, additional, Park, Kyun-Ik, additional, Lee, Seung-Pyo, additional, Lee, Hee-Sun, additional, Lee, Ju-Yeun, additional, Kim, Kwang-il, additional, Kang, Si-Hyuck, additional, Lee, Jang Hoon, additional, Jang, Se Yong, additional, Lee, Ju-Hee, additional, Kim, Kye Hun, additional, Cho, Jae Yeong, additional, Park, Jae-Hyeong, additional, Park, Sue K., additional, and Lee, Hae-Young, additional

Published
2023
Full Text
View/download PDF

31. Prognostic impact of chromogranin A in patients with acute heart failure

Author

Kim, Hong Nyun, Yang, Dong Heon, Park, Bo Eun, Park, Yoon Jung, Kim, Hyeon Jeong, Jang, Se Yong, Bae, Myung Hwan, Lee, Jang Hoon, Park, Hun Sik, Cho, Yongkeun, and Chae, Shung Chull

Subjects
Medicine (General), endocrine system, Prognosis prediction, medicine.medical_specialty, medicine.drug_class, Composite event, heart failure, Gastroenterology, R5-920, Internal medicine, Natriuretic peptide, Medicine, In patient, Adverse effect, biology, business.industry, Mortality rate, chromogranin a, biomarkers, Chromogranin A, medicine.disease, Heart failure, biology.protein, Original Article, prognosis, business
Abstract

Background: Chromogranin A (CgA) levels have been reported to predict mortality in patients with heart failure. However, information on the prognostic value and clinical availability of CgA is limited. We compared the prognostic value of CgA to that of previously proven natriuretic peptide biomarkers in patients with acute heart failure.Methods: We retrospectively evaluated 272 patients (mean age, 68.5±15.6 years; 62.9% male) who underwent CgA test in the acute stage of heart failure hospitalization between June 2017 and June 2018. The median follow-up period was 348 days. Prognosis was assessed using the composite events of 1-year death and heart failure hospitalization.Results: In-hospital mortality rate during index admission was 7.0% (n=19). During the 1-year follow-up, a composite event rate was observed in 12.1% (n=33) of the patients. The areas under the receiver-operating characteristic curves for predicting 1-year adverse events were 0.737 and 0.697 for N-terminal pro-B-type natriuretic peptide (NT-proBNP) and CgA, respectively. During follow-up, patients with high CgA levels (>158 pmol/L) had worse outcomes than those with low CgA levels (≤158 pmol/L) (85.2% vs. 58.6%, p

Published
2021

32. Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: Insight from the Korean Hypertension Cohort Study

Author

Park, Bo Eun, primary, Lee, Jang Hoon, additional, Jang, Se Yong, additional, Lee, Hae‐Young, additional, Lee, Ju‐Yeon, additional, Shin, Ho‐Gyun, additional, Park, Kyun‐Ik, additional, Lee, Seung‐Pyo, additional, Lee, Hee‐Sun, additional, Kim, Kwang‐Il, additional, Kang, Si‐Hyuck, additional, Lee, Ju‐Hee, additional, Kim, Kye Hun, additional, Cho, Jae Yeong, additional, Park, Jae‐Hyeong, additional, Park, Sue K., additional, Bak, Jean Kyung, additional, and Lee, Jin Young, additional

Published
2022
Full Text
View/download PDF

34. Preoperative cardiac troponin I as a predictor of postoperative cardiac events in patients with end stage renal disease undergoing non-cardiac surgery

Author

Park, Bo Eun, primary, Bae, Myung Hwan, additional, Park, Yoon Jung, additional, Kim, Hong Nyun, additional, Kim, Namkyun, additional, Jang, Se Yong, additional, Lee, Jang Hoon, additional, Yang, Dong Heon, additional, Park, Hun Sik, additional, Cho, Yongkeun, additional, and Chae, Shung Chull, additional

Published
2022
Full Text
View/download PDF

43. Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA2DS2‐VASc score of 0.

Author

Choi, Hyohun, Bae, Myung Hwan, Park, Yoon Jung, Park, Hyuk Kyoon, Lee, Eunkyu, Kim, Myeong Seop, Park, Jong Sung, Kim, Hyeon Jeong, Park, Bo Eun, Kim, Hong Nyun, Kim, Namkyun, Lee, Jang Hoon, Jang, Se Yong, Yang, Dong Heon, Park, Hun Sik, and Cho, Yongkeun

Abstract

Background: Anticoagulant therapy has been important for stroke prevention in patients with atrial fibrillation (AF). However, it was not recommended due to its relatively higher risk of bleeding than its lower risk of stroke in patients with a CHA2DS2‐VASc score of 0. Hypothesis: This study aimed to evaluate the predictors of stroke in AF patients with very low risk of stroke. Methods: Between 1990 and 2020, 542 patients with non‐valvular AF (NVAF) with a CHA2DS2‐VASc score of 0 followed up for at least 6 months were enrolled. Patients with only being woman as a risk factor were included as a CHA2DS2‐VASc score of 0 in this study. The primary outcome was stroke or systemic embolism. Results: The primary outcome rate was 0.78%/year. In Cox hazard model, age of ≥50 years at diagnosis (hazard ratio [HR] 6.710, 95% confidence interval [CI] 1.811–24.860, p =.004), LVEDD of ≥46 mm (HR 4.513, 95% CI 1.038–19.626, p =.045), and non‐paroxysmal AF (HR 5.575, 95% CI 1.621–19.175, p =.006) were identified as independent predictors of stroke or systemic embolism. Patients with all three independent predictors had a higher risk of stroke or systemic embolism (4.21%/year), whereas those without did not have a stroke or systemic embolism. Conclusion: The annual stroke or systemic embolism rate in NVAF patients with CHA2DS2‐VASc score of 0 was 0.78%/year, and age at AF diagnosis, LVEDD, and non‐paroxysmal AF were independent predictors of stroke or systemic embolism in patients considered to have a very low risk of stroke. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

44. Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction

Author

Choi, Hyohun, primary, Lee, Jang Hoon, additional, Park, Hyuk Kyoon, additional, Lee, Eunkyu, additional, Kim, Myeong Seop, additional, Kim, Hyeon Jeong, additional, Park, Bo Eun, additional, Kim, Hong Nyun, additional, Kim, Namkyun, additional, Jang, Se Yong, additional, Bae, Myung Hwan, additional, Yang, Dong Heon, additional, Park, Hun Sik, additional, and Cho, Yongkeun, additional

Published
2022
Full Text
View/download PDF

48. The Korean Hypertension Cohort study: design and baseline characteristics

Author

Lee, Hae-Young, primary, Lee, Ju-Yeon, additional, Shin, Ho-Gyun, additional, Cho, Song-Hee, additional, Park, Kyun-Ik, additional, Oh, Gyu-Chul, additional, Lee, Seung-Pyo, additional, Kim, Hogon, additional, Lee, Hee-Sun, additional, Kim, Kwang-Il, additional, Kang, Si-Hyuck, additional, Lee, Jang Hoon, additional, Jang, Se Yong, additional, Lee, Ju-Hee, additional, Kim, Kye Hun, additional, Cho, Jae Yeong, additional, Park, Jae-Hyeong, additional, Jang, Jieun, additional, Park, Sue K., additional, and Bak, Jean Kyung, additional

Published
2021
Full Text
View/download PDF

49. Additional file 1 of Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus

Author

Jang, Se Yong, Jang, Jieun, Yang, Dong Heon, Cho, Hyun-Jai, Lim, Soo, Jeon, Eun-Seok, Lee, Sang Eun, Kim, Jae-Joong, Kang, Seok-Min, Baek, Sang Hong, Cho, Myeong-Chan, Choi, Dong-Ju, Yoo, Byung-Su, Kim, Kye Hun, Park, Sue K., and Lee, Hae-Young

Abstract

Additional file 1: Figure S1. Flow chart for study subject selection. Table S1. Composition of the oral hypoglycemic medication for the OHA-only group and both OHAs and insulin group. Table S2. Insulin treatment in KorAHF registry. Table S3. Mortality rates according to hypoglycemic therapy among the patients with diabetes and heart failure. Table S4. Association between diabetes therapy and overall mortality according to age in the pseudo-cohort. Table S5. Association between diabetes therapy and overall mortality according to sex in the pseudo-cohort. Table S6. Association between diabetes therapy and overall mortality according to ischemic etiology in the pseudo-cohort. Table S7. Association between diabetes therapy and overall mortality according to left ventricular ejection fraction in the pseudo-cohort. Table S8. Association between diabetes therapy and overall mortality according to glycated hemoglobin levels in the pseudo-cohort. Table S9. Association between diabetes therapy and overall mortality according to severity of heart failure in the pseudo-cohort. Table S10. Overall mortality according to diabetes therapy in stratified population by diabetes mellitus medication in the weighted pseudo-cohort.

Published
2021
Full Text
View/download PDF

50. sj-pdf-1-eji-10.1177_20587392211039095 – Supplemental Material for Prognostic value of novel neutrophil-to-hemoglobin and lymphocyte score in patients with acute myocardial infarction

Author

Kim, Hyeon Jeong, Lee, Jang Hoon, Jang, Se Yong, Bae, Myung Hwan, Yang, Dong Heon, Park, Hun Sik, Cho, Yongkeun, Jeong, Myung H, Park, Jong-Seon, Kim, Hyo-Soo, Hur, Seung-Ho, Seong, In-Whan, Cho, Myeong-Chan, and Chae, Shung Chull

Subjects
110203 Respiratory Diseases, 70706 Veterinary Medicine, FOS: Clinical medicine, FOS: Veterinary sciences, Cell Biology, FOS: Health sciences, Biochemistry, FOS: Biological sciences, Medicine, 110309 Infectious Diseases, 111702 Aged Health Care, 111403 Paediatrics, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 69999 Biological Sciences not elsewhere classified
Abstract

Supplemental Material, sj-pdf-1-eji-10.1177_20587392211039095 for Prognostic value of novel neutrophil-to-hemoglobin and lymphocyte score in patients with acute myocardial infarction by Hyeon Jeong Kim, Jang Hoon Lee, Se Yong Jang, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Myung H Jeong, Jong-Seon Park, Hyo-Soo Kim, Seung-Ho Hur, In-Whan Seong, Myeong-Chan Cho and Shung Chull Chae in European Journal of Inflammation

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results